Back to results

(BPCP)

Buy:
73.20 p
Sell:
71.40 p
Change:
1.50 (2.07%)
Open an account

BioPharma Credit (BPCP)

BioPharma Credit

ISIN:

GB00BDGKMY29

Benchmark:

N/A

Trading on:

London Stock Exchange

Buy:
73.20 p
Sell:
71.40 p
Change:
1.50 (2.07%)
Updated at: 17/07/2026 - 16:46
*Prices delayed by at least 15 minutes
Key Investor Information Document (KIID)
At a glance

At a glance performance and information

Trading update:

Opening price:

74.00 p

Previous close:

71.00 p

Day High / Low:

74.00 p - 71.00 p

52 week High / Low:

74.00 p - 64.50 p

Volume:

458,609.00

Fundamentals:

Market capitalisation:

£ 801,751,698.14

Total assets:

N/A

Published NAV:

N/A

Premium + / Discount – (%):

N/A

Gross gearing:

N/A

Dividends:

Last dividend:

USX 1.75 (31/10/2025)

Dividend yield:

6.02%

Next dividend:

N/A (N/A)

Ex-Dividend date:

N/A

Click to see dividend history

Eligibility:

Share Dealing Account
ISA
SIPP

Investing for longer increases the likelihood of positive returns. Over a period of 5 years or more, investments usually give you a higher return compared to cash savings. But investments can go down as well as up in value. So you could get back less than you put in.

Intraday 1 W 1 M 3 M 6 M YTD 1 Y 3 Y 5 Y Max
Advanced Chart

Dividend overview

Last dividend:

USX 1.75 (31/10/2025)

Dividend yield:

6.02%

Next dividend:

N/A (N/A)

Ex-Dividend date:

N/A

Dividend data

Year End Amount Payment Date Ex-Div Date Record Date
31-Dec-2025 USX 1.75 31-Oct-25 25-Sep-25 N/A
USX 2.2866 28-Feb-25 30-Jan-25 N/A
31-Dec-2023 USX 1.75 15-Sep-23 17-Aug-23 N/A
USX 1.3693 26-May-23 27-Apr-23 N/A
USX 3.3291 28-Apr-23 30-Mar-23 N/A
31-Dec-2022 USX 1.75 18-Nov-22 20-Oct-22 N/A
USX 1.75 23-Sep-22 25-Aug-22 N/A
USX 1.75 31-May-22 05-May-22 N/A
USX 1.75 31-Mar-22 03-Mar-22 N/A
31-Dec-2021 USX 1.303 17-Dec-21 18-Nov-21 N/A
Fees & charges

Fees and Charges

Fees and Charges
Charge Who receives this? What is it? Amount
Ongoing Charges: The fund manager The annual charge paid to a fund manager to cover the costs of running the fund. It is an estimate based on the actual amount charged in the previous year. 1.20%
Typical transaction cost: The fund manager The costs of dealing within a fund, which the Investment Manager must pay to continue managing the assets. This includes where the Manager decides to sell one stock and buy another. The costs will vary from one fund to another based on how often the Investment Manager trades and the costs applied when trading. 0.188%*
Dealing commission: Scottish Widows The cost of buying or selling some or all of your investment. £5.00 (per online trade)

*This is an indication based on the market average. The fund’s actual transaction cost will be shown before you place a trade.

Account charges are not included

Breakdown

FE fundinfo Rating:

N/A

Share type:

Income

Dividend frequency:

No dividends

12 month dividend yield:

6.02%

Ex-Dividend date:

N/A

Top 10 Holdings
Top 10 Holdings
Security Weight
Insmed incorporated 18.63%
Novocure loan 8.43%
Evolus loan 5.32%
Urogen pharma ltd ord 4.27%
Geron loan 4.20%
Precigen loan 4.19%
Tarsus loan 3.16%
Harrow equity 3.13%
Cytokinetics equity 3.07%
Alphatec loan 3.01%
Sectors
Sectors
Sector Weight
Health Care 63.68%
Money Market 36.32%
World regions
World regions
Country Weight
USA 78.42%
Cash 12.52%
EU 8.42%
UK 0.64%